Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.

Lim E. et al, (2022), Health Technol Assess, 26, 1 - 162

Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.

Briggs SEW. et al, (2022), BMJ, 379

Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.

Huygens S. et al, (2022), Value Health

Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial.

Llewelyn MJ. et al, (2022), Lancet Infect Dis

Resource allocation in genetic and genomic medicine.

Buchanan J. et al, (2022), J Community Genet

Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients.

Tsiachristas A. et al, (2022), BMC Cancer, 22

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Dixon P. et al, (2022), Genetics in Medicine

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Dixon P. et al, (2022), Genetics in Medicine

Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.

Benger JR. et al, (2022), Health Technol Assess, 26, 1 - 158

The net benefit of personalised medicine: A systematic literature review and regression analysis.

Vellekoop H. et al, (2022), Value in Health

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Article

Koleva-Kolarova R. et al, (2022), Applied Health Economics and Health Policy

Defining a Core Data Set for the Economic Evaluation of Precision Oncology.

Pollard S. et al, (2022), Value Health

Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.

Yang M. et al, (2022), Health Econ

Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer

Lim E. et al, (2022), NEJM Evidence, 1

Cost-effectiveness of targeted genomic risk provision to prevent skin cancer: Results of a randomized trial.

Law CK. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40

WHAT IS THE NET ADDED VALUE OF PERSONALISED MEDICINE? A SYSTEMATIC LITERATURE REVIEW

Vellekoop H. et al, (2022), VALUE IN HEALTH, 25, S75 - S75

Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets.

Buckell J. et al, (2021), Health Econ

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.

100,000 Genomes Project Pilot Investigators None. et al, (2021), N Engl J Med, 385, 1868 - 1880

Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice.

Borek AJ. et al, (2021), Implement Sci Commun, 2

Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: a choice experiment

MORRELL E., (2021), PLoS Medicine

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?